Nicholas Mark Johnson
CIK: 0002108270
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MED
MEDIFAST INC
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Johnson Nicholas Mark
Johnson Nicholas Mark (SEC CIK 0002108270) files insider reports with the SEC as President of MEDIFAST INC (MED).
Signal8 holds 1 ownership filing by Johnson Nicholas Mark, a Form 3, filed on Mar 27, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Johnson Nicholas Mark's filings is in BALTIMORE, MD.
Other insiders filing for MEDIFAST INC (MED)
- Kiai Parsa, Director
- Rose Jeffrey Matthew, Director
- Thomas Andrea B, Director
- SCHLACKMAN SCOTT, Director
- Geary Elizabeth A., Director
- Xian Ming, Director